Literature DB >> 7752127

Costs of osteoarthritis: estimates from a geographically defined population.

S E Gabriel1, C S Crowson, W M O'Fallon.   

Abstract

Using the population based data resources of the Rochester Epidemiology Project and a postal survey, we estimated all costs (direct medical, indirect medical, and nonmedical) incurred among a population based prevalence cohort of individuals with osteoarthritis (OA) and a nonarthritic comparison cohort. Cost estimates were compared between the 2 groups adjusting for age and sex differences. Our results demonstrated that people with OA incur substantial incremental medical costs, not only for arthritis care, but also for the care of neurological, gastrointestinal, cardiac, and respiratory conditions compared to nonarthritics. These data also demonstrated important and statistically significantly higher levels of work disability among people with OA compared to their age and sex adjusted peers without arthritis from the same community.

Entities:  

Mesh:

Year:  1995        PMID: 7752127

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  10 in total

1.  Barriers to accessing the culturally sensitive healthcare that could decrease the disabling effects of arthritis in a rural Mayan community: a qualitative inquiry.

Authors:  Adalberto Loyola-Sanchez; Julie Richardson; Seanne Wilkins; John N Lavis; Michael G Wilson; Jose Alvarez-Nemegyei; Ingris Pelaez-Ballestas
Journal:  Clin Rheumatol       Date:  2015-09-03       Impact factor: 2.980

2.  Health-Related Quality-of-Life Outcomes in Patients Treated with Push-Pull OROS Hydromorphone versus Extended-Release Oxycodone for Chronic Hip or Knee Osteoarthritis Pain: A Randomized, Open-Label, Parallel-Group, Multicenter Study.

Authors:  Kavita Gajria; Mark Kosinski; Jeff Schein; Shane Kavanagh; Dominique Dubois
Journal:  Patient       Date:  2008-07-01       Impact factor: 3.883

Review 3.  Economic evaluation of the management of pain in osteoarthritis.

Authors:  P Tugwell
Journal:  Drugs       Date:  1996       Impact factor: 9.546

4.  Evidence-Based Decision Making 6: Administrative Databases as Secondary Data Source for Epidemiologic and Health Service Research.

Authors:  Tanvir Turin Chowdhury; Brenda R Hemmelgarn
Journal:  Methods Mol Biol       Date:  2021

Review 5.  The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases.

Authors:  Hilal Maradit Kremers; Elena Myasoedova; Cynthia S Crowson; Guergana Savova; Sherine E Gabriel; Eric L Matteson
Journal:  Rheumatology (Oxford)       Date:  2010-07-13       Impact factor: 7.580

Review 6.  Chondroitin for osteoarthritis.

Authors:  Jasvinder A Singh; Shahrzad Noorbaloochi; Roderick MacDonald; Lara J Maxwell
Journal:  Cochrane Database Syst Rev       Date:  2015-01-28

7.  Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty.

Authors:  Elena Losina; A David Paltiel; Alexander M Weinstein; Edward Yelin; David J Hunter; Stephanie P Chen; Kristina Klara; Lisa G Suter; Daniel H Solomon; Sara A Burbine; Rochelle P Walensky; Jeffrey N Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-02       Impact factor: 4.794

8.  Assessment of a genetic contribution to osteoarthritis of the hip: sibling study.

Authors:  P Lanyon; K Muir; S Doherty; M Doherty
Journal:  BMJ       Date:  2000-11-11

9.  Osteoarthritis and the impact on quality of life health indicators.

Authors:  Chad Cook; Ricardo Pietrobon; Eric Hegedus
Journal:  Rheumatol Int       Date:  2006-11-15       Impact factor: 2.631

10.  The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study.

Authors:  A Maetzel; L C Li; J Pencharz; G Tomlinson; C Bombardier
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.